Novolog (Pharm-Up 1966) Ltd (NVLG.TA)
ILA 155.0
(2.85%)
ILA 155.0
(2.85%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.64 Billion ILS | 8.99% |
| 2022 | 1.5 Billion ILS | 20.13% |
| 2021 | 1.25 Billion ILS | 10.73% |
| 2020 | 1.13 Billion ILS | 12.9% |
| 2019 | 1 Billion ILS | 10.19% |
| 2018 | 911.23 Million ILS | 8.5% |
| 2017 | 839.83 Million ILS | 13.61% |
| 2016 | 739.21 Million ILS | 8.18% |
| 2015 | 683.3 Million ILS | 8.63% |
| 2014 | 629 Million ILS | 15.88% |
| 2013 | 542.78 Million ILS | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 438.04 Million ILS | 10.49% |
| 2024 Q2 | 427.96 Million ILS | -2.3% |
| 2023 FY | 1.64 Billion ILS | 8.99% |
| 2023 Q1 | 413.19 Million ILS | 7.76% |
| 2023 Q4 | 396.45 Million ILS | -5.78% |
| 2023 Q2 | 413.05 Million ILS | -0.03% |
| 2023 Q3 | 420.78 Million ILS | 1.87% |
| 2022 Q1 | 375.37 Million ILS | 25.26% |
| 2022 FY | 1.5 Billion ILS | 20.13% |
| 2022 Q4 | 383.45 Million ILS | -1.1% |
| 2022 Q3 | 387.73 Million ILS | 7.29% |
| 2022 Q2 | 361.38 Million ILS | -3.72% |
| 2021 Q3 | 329.85 Million ILS | 6.52% |
| 2021 FY | 1.25 Billion ILS | 10.73% |
| 2021 Q2 | 309.65 Million ILS | -2.03% |
| 2021 Q1 | 316.07 Million ILS | 15.46% |
| 2021 Q4 | 299.66 Million ILS | -9.15% |
| 2020 Q3 | 290.5 Million ILS | 8.41% |
| 2020 Q1 | 302.12 Million ILS | 34.62% |
| 2020 Q2 | 267.96 Million ILS | -11.31% |
| 2020 FY | 1.13 Billion ILS | 12.9% |
| 2020 Q4 | 273.75 Million ILS | -5.76% |
| 2019 Q2 | 247.93 Million ILS | -6.67% |
| 2019 FY | 1 Billion ILS | 10.19% |
| 2019 Q4 | 224.43 Million ILS | -15.83% |
| 2019 Q3 | 266.63 Million ILS | 7.55% |
| 2019 Q1 | 265.65 Million ILS | 20.08% |
| 2018 Q1 | 231.09 Million ILS | 3.9% |
| 2018 FY | 911.23 Million ILS | 8.5% |
| 2018 Q4 | 221.23 Million ILS | -3.77% |
| 2018 Q3 | 229.9 Million ILS | 0.39% |
| 2018 Q2 | 229.01 Million ILS | -0.9% |
| 2017 Q2 | 199.12 Million ILS | -4.9% |
| 2017 Q3 | 208.91 Million ILS | 4.91% |
| 2017 FY | 839.83 Million ILS | 13.61% |
| 2017 Q4 | 222.41 Million ILS | 6.46% |
| 2017 Q1 | 209.38 Million ILS | 16.7% |
| 2016 Q1 | 178.13 Million ILS | 4.85% |
| 2016 Q4 | 179.42 Million ILS | -6.62% |
| 2016 FY | 739.21 Million ILS | 8.18% |
| 2016 Q3 | 192.14 Million ILS | 1.38% |
| 2016 Q2 | 189.52 Million ILS | 6.39% |
| 2015 FY | 683.3 Million ILS | 8.63% |
| 2015 Q3 | 161.8 Million ILS | 0.0% |
| 2015 Q4 | 169.89 Million ILS | 5.0% |
| 2014 FY | 629 Million ILS | 15.88% |
| 2013 FY | 542.78 Million ILS | 0.0% |
| Name | Revenue | Revenue Difference |
|---|